Daxxin

Daxxin is a Swedish dermatological scalp-care brand that develops shampoos and washes for dandruff, dry scalp, itching and mild-to-moderate psoriasis. It is marketed and distributed by Allderma AB, a Stockholm-based pharmaceutical company that handles dermatology, trichology and probiotic products for the Nordic market [2]. The range is sold mainly through pharmacies, and the company positions Daxxin as a specialist in scalp problems rather than a general hair-care line.

According to the company, the products are developed in collaboration with doctors, hair-care specialists and chemists, and manufactured in Sweden [1]. The brand remains active: its own FAQ describes Daxxin as the market leader for scalp products in Swedish pharmacies, citing IQVIA data from June 2025 [4].

⚑ Thinner sourcing. The article relies largely on the brand's own statements (T2–T3). Glowpedia is seeking independent sources.

No public source records a founding year, named founder or early company history for Daxxin, and the brand's own pages do not state when it began. What is documented is its relationship to Allderma AB, the Swedish pharmaceutical company that markets and distributes the line. Allderma describes its mission as helping patients and healthcare providers with effective products across dermatology, trichology and probiotics in the Nordics, working "through quality and innovation" [2].

Daxxin sits within a broader Allderma portfolio of dermatological and medical products that also includes Terclara, Lactiplus, Hårkontroll and Trans-ver-sal, among others. The brand's commercial identity is therefore that of a focused scalp-care line operating under an established pharmaceutical distributor rather than an independent start-up.

Daxxin presents itself as a specialist in scalp conditions, with the stated aim of products that work well yet stay mild enough for daily use. Its homepage descriptor reads "Daxxin är specialist på hårbottenproblem" (Daxxin is a specialist in scalp problems), and the company frames its appeal around reliability — that people value the products because they genuinely work and can be used as often as wanted. The Swedish tagline, "Bli av med mjällen... På riktigt" ("Get rid of dandruff... For real"), signals the same efficacy-first message.

The positioning balances potency with tolerability. Across its dandruff range the brand describes formulas as "effective against dandruff but mild and gentle enough for daily use," offered in both fragrance-free and lightly fragranced variants. Products are pitched at people with persistent dandruff, seborrheic eczema, dry scalp and psoriasis, including those with sensitive scalps; the FAQ states most products are suitable from age three, while the psoriasis shampoo is recommended for adults only [4].

The line centres on medicated shampoos and body washes grouped by scalp concern. Signature products include a Triple Acting Anti-Dandruff Shampoo, a Pre-Wash Anti-Dandruff treatment, an Intense Treatment for dry scalp, a Psoriasis Shampoo, and the Daxxin PSO Body Wash, which the company states is built on the same formulation as the Psoriasis Shampoo [5]. A separate conditioner is sold for use alongside the shampoos.

The brand attributes results to what it calls a triple-action formula — a single product meant to address the scalp problem, calm irritation and condition the hair at once. Notably, Daxxin does not disclose its active ingredients: neither the brand's product and category pages nor third-party reviewers name the agents behind the formulas, an unusual reticence for a medicated scalp range. The company says its products are free from sulfates, silicones, parabens, PFAS, phthalates, colour additives and nanoparticles, and that the entire range is vegan [4].

On positioning within the wider market, Daxxin is described as a drugstore-tier, pharmacy-distributed brand. The company states the products are sold through Nordic pharmacies and dermatology clinics via the distributors Tamro and Oriola [3], and the line is stocked by major Swedish pharmacy chains including Apotek Hjärtat, Kronans Apotek, Apoteket and Apotea.

Daxxin places clinical testing at the centre of its marketing, gathering its results under a "Bevisat effektiva" (Proven Effective) page. Most of the cited studies are small user-perception trials. An external study of the Anti-Dandruff Shampoo (20 participants, eight weeks) reported that 90% felt their scalp was healthier and 80% agreed the product removed dandruff, while a four-week Pre-Wash study of the same size reported 95% perceiving a cleaner, healthier scalp [3].

The most substantial evidence concerns the psoriasis line. The company cites a 60-patient study led by Dr Gånemo, an associate professor at Lund University, in which more than half of patients reported itching and scaling as "much better or better," and a follow-up user survey found 93% of psoriasis patients satisfied with the shampoo [3]. The brand also notes that its products are registered with the Swedish Medical Products Agency and the European CPNP, and that it acts as the responsible Pi-holder for the formulations.

Daxxin has not been covered by major international beauty press, which is typical for a regional Nordic pharmacy brand. Within Sweden it has appeared in dandruff-shampoo comparison round-ups: the niche Swedish review site Lush Bodys ranked Daxxin first in its 2026 "Bäst i Test Mjällschampo" (best-in-test dandruff shampoo) feature, giving it an overall 4.8 out of 5 and placing it ahead of competitors such as Fungoral, Maria Nila, Aco and Selsun [13]. The reviewer described it as one of the more effective dandruff shampoos on the market while remaining mild in use [12].

Daxxin is an active, Nordic-focused brand. It maintains a live multilingual website with Swedish, English, Finnish, Norwegian and Danish versions, and the company reports recent commercial standing — most notably a market-leader claim for Swedish pharmacies based on IQVIA data dated June 2025. According to the brand's own statements, it is also positioned as a leading medical hair-care brand in Norway, and its psoriasis line is available in Sweden, Norway and Denmark [1]. Its scope is regional rather than global.